Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr:72:216-217.
doi: 10.1016/j.avsg.2020.12.006. Epub 2020 Dec 30.

The COVID-19 Arterial Thromboembolic Complications: From Inflammation to Immunothrombosis Through Antiphospholipid Autoantibodies

Affiliations
Comment

The COVID-19 Arterial Thromboembolic Complications: From Inflammation to Immunothrombosis Through Antiphospholipid Autoantibodies

Luca Roncati et al. Ann Vasc Surg. 2021 Apr.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Surgical specimen histopathology from a 72-year-old Italian male patient affected by severe COVID-19: (A) complete thrombosis of the medium-sized splenic artery [hematoxylin and eosin, x2.5 objective]: (B) neutrophils infiltration accompanied by karyorrhexis inside the tunica media and adventitia, a classical picture of “leukocytoclastic vasculitis”, with a still preserved endothelial layer [hematoxylin and eosin, x10 objective]; (C) immunohistochemistry for CD61 reveals platelets interaggregating and adhering to the endothelial cells (black arrows), together with occlusive microthromboses of vasa vasorum (red arrows) [2f2 clone, x10 objective]; (D) the platelets aggregates, adhering tenaciously to the endothelium, contain also blue-stained fibrin (blue arrows) [phosphotungstic acid hematoxylin, x10 objective].

Comment on

Similar articles

Cited by

References

    1. Indes J.E., Koleilat I., Hatch A.N., et al. Early experience with arterial thromboembolic complications in patents with COVID-19. J Vasc Surg. 2020 doi: 10.1016/j.jvs.2020.07.089. - DOI - PMC - PubMed
    1. Guervilly C., Burtey S., Sabatier F., et al. Circulating endothelial cells as a marker of endothelial injury in severe COVID-19. J Infect Dis. 2020;222:1789–1793. - PMC - PubMed
    1. Roncati L., Gallo G., Manenti A., et al. Renin-angiotensin system: the unexpected flaw inside the human immune system revealed by SARS-CoV-2. Med Hypotheses. 2020;140:109686. - PMC - PubMed
    1. Varga Z., Flammer A.J., Steiger P., et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–1418. - PMC - PubMed
    1. Roncati L., Ligabue G., Fabbiani L., et al. Type 3 hypersensitivity in COVID-19 vasculitis. Clin Immunol. 2020;217:108487. - PMC - PubMed